Sysmex, Japan Cancer Center Join To Develop Cancer-Drug Diagnostics
This article was originally published in PharmAsia News
Executive Summary
Sysmex and Japan's National Cancer Center have formed a partnership to develop diagnostic drugs for cancer, with the center doing the discovery work and Sysmex marketing the technology and biomarkers.